Menu Search
Equities

Japan Medical Dynamic Marketing Inc

JMD:FRA

Japan Medical Dynamic Marketing Inc

Actions
  • Price (EUR)3.60
  • Today's Change0.02 / 0.56%
  • Shares traded-1.00
  • 1 Year change-40.98%
  • Beta--
Data delayed at least 15 minutes, as of Jun 03 2024 07:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Japan Medical Dynamic Marketing, INC. is a Japan-based medical equipment provider. The Company is principally engaged in the import, development, manufacture and sale of medical equipment primarily in the field of orthopedic surgery. The Company has two segments. The Japan segment imports materials for osteosynthesis, artificial joints and spinal fixation devices from manufacturers, and sell them in Japan. The America segment is involved in the development and manufacture of materials for osteosynthesis, artificial joints, spinal fixation devices and other products, as well as the sale of medical equipment in North America. As of March 31, 2014, the Company had one subsidiary in the United States.

  • Revenue in JPY (TTM)23.18bn
  • Net income in JPY1.27bn
  • Incorporated1973
  • Employees488.00
  • Location
    Japan Medical Dynamic Marketing Inc12-2, Ichigayadai-machiSHINJUKU-KU 162-0066JapanJPN
  • Phone+81 333416545
  • Fax+81 333416752
  • Websitehttps://www.jmdm.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.